VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $773,000 | -11.7% | 32,032 | +40.4% | 0.06% | -7.7% |
| Q1 2022 | $875,000 | +33.4% | 22,821 | +11.4% | 0.06% | +16.1% |
| Q4 2021 | $656,000 | +39.3% | 20,482 | +28.3% | 0.06% | +51.4% |
| Q3 2021 | $471,000 | -14.5% | 15,970 | -1.6% | 0.04% | -11.9% |
| Q2 2021 | $551,000 | +88.1% | 16,224 | +79.9% | 0.04% | +68.0% |
| Q1 2021 | $293,000 | +11.4% | 9,019 | +23.6% | 0.02% | +4.2% |
| Q4 2020 | $263,000 | -96.0% | 7,294 | -97.0% | 0.02% | -97.2% |
| Q3 2019 | $6,529,000 | +28.9% | 244,456 | +23.3% | 0.86% | +21.9% |
| Q2 2019 | $5,066,000 | +138.4% | 198,199 | +96.7% | 0.70% | +212.9% |
| Q4 2018 | $2,125,000 | +6.6% | 100,764 | +11.1% | 0.22% | +45.2% |
| Q1 2018 | $1,994,000 | +40.4% | 90,700 | +45.6% | 0.16% | -48.3% |
| Q1 2017 | $1,420,000 | – | 62,300 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |